The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $730,609 in first-year total cost, median $237,817.
Most frequent study sections
- Special Emphasis Panel[ZHD1 DSR-Z (50)]3
Most frequent institutions
- MICHIGAN STATE UNIVERSITY1
- OHIO STATE UNIVERSITY1
- STANFORD UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Stem cell epigenetics in uterine fibroids1R21HD102907-01 | TEIXEIRA, JOSE M. | MICHIGAN STATE UNIVERSITY, MI | $258,792 | ZHD1 |
| 2020 | Stem cell-derived smooth muscle progenitor cells for vaginal wall prolapse1R21HD102224-01 | CHEN, BERTHA | STANFORD UNIVERSITY, CA | $237,817 | ZHD1 |
| 2020 | In vivo Identification of stem cells in MED12 mutant leiomyoma1R21HD102897-01 | KURITA, TAKESHI | OHIO STATE UNIVERSITY, OH | $234,000 | ZHD1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.